Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04166903
Other study ID # ProMagIC-Study
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 15, 2019
Est. completion date December 2020

Study information

Verified date March 2020
Source Technische Universität München
Contact Michael Schindler, MD
Phone +49 (0) 89 289 24441
Email Michael.Schindler@mri.tum.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Pro-MagIC is a prospective observational study and includes participants of the Be-MaGIC-Study 2009 (n=277/NCT00933218). We aim to detect exercise-induced physiological changes (inter alia of the cardiovascular system) induced by repetitive ultra-endurance strain over a period of 10 years.


Description:

Physical activity is associated with health benefits. Acute prolonged and strenuous exercise, i.e. Marathon running, leads to hemodynamic, endothelial and myocardial functional changes. Whether these myocardial, endothelial and hemodynamic changes can also develop and persist through repetitive extreme and prolonged physical activity is currently still a matter of controversy. In addition, it is not known whether adaptations and changes over time can develop into clinically relevant cardiovascular events with negative health consequences in healthy athletes. The aim of this study is to detect exercise-induced physiological changes (inter alia of the cardiovascular system) induced by repetitive ultra-endurance strain over a period of 10 years.

For this purpose, 277 male participants from the Be-MaGIC study (Marathon 2009) are examined in this prospective observational study. A single examination with the following components will take place: Anthropometry, clinical examination, laboratory, resting / exercise electrocardiography cardiopulmonary stress test, echocardiography, and fundus camera. Further examinations will be conducted in participants with abnormal examination results in line with current clinical recommendations.


Recruitment information / eligibility

Status Recruiting
Enrollment 277
Est. completion date December 2020
Est. primary completion date March 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 30 Years to 70 Years
Eligibility Inclusion Criteria:

Declaration of consent Participants must have participated in the Be-MaGIC study in 2009

- current age: 30 - 70 years

- sex: male

Exclusion Criteria:

-

Study Design


Related Conditions & MeSH terms

  • Participants of the Be-MaGIC-Study 2009

Locations

Country Name City State
Germany Department of Prevention, Rehabilitation and Sports Medicine, Munich, Germany Munich Bavaria

Sponsors (3)

Lead Sponsor Collaborator
Technische Universität München Balgrist University Hospital, Deutsches Herzzentrum Muenchen

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes of right ventricular systolic function (RV-EF) Echocardiography 10 years
Secondary Changes in left ventricular ejection fraction (LV-EF) Echocardiography 10 years
Secondary Changes in left ventricular diastolic function (E/e´) Echocardiography 10 years
Secondary Change in cardiac markers (e.g. cardiac Troponin) Clinical chemistry (blood samples) 10 years
Secondary Change in inflammation markers (e.g. C-reactive Protein) Clinical chemistry (blood samples) 10 years
Secondary Change in microcirculation (e.g. arteriolar-to-venular ratio) Static Retinal Vessel Analyzer 10 years
Secondary Change in macrocirculation (e.g. Intima media thickness) Carotid sonography 10 years
Secondary Change of prevalence of cardiovascular diseases Questionnaire 10 years
Secondary Association between changes of aforementioned parameters (see Topics 1-8) and potential underlying causes (e.g. sports history like number of ultraendurance competitions) in the examined cohort 10 years